Invokana Amputation Lawyer Discusses Clinical Trials and FDA Warnings

On May 16, 2017, the U.S. Food and Drug Administration (FDA) posted a safety alert regarding amputation risks associated with the diabetes medication Canagliflozin (Invokana, Invokamet XR and Invokamet). An Invokana Amputation Lawyer at the F&A Injury Law Firm in New York, NY explains that this FDA alert included a “black box warning,” which the FDA says is “designed […]